跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
ABIRATERONE-TEVA FC TABLET 500 MG
Approved
THERAPEUTIC
ABIRATERONE-TEVA FC TABLET 500 MG
TEVA Pharmaceutical Industries, Ltd.
🇸🇬 Health Sciences Authority
Approval Date
Apr 18, 2024
Approval ID
2ed6021f0d349561
Company
TEVA Pharmaceutical Industries, Ltd.
Type
Therapeutic
Approval Details
Approval Id
2ed6021f0d349561
Drug Name
ABIRATERONE-TEVA FC TABLET 500 MG
Product Name
ABIRATERONE-TEVA FC TABLET 500 MG
Approval Number
SIN16987P
Approval Date
2024-04-18
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
L02BX03
Atc Item Name
abiraterone
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Abiraterone acetate
500 mg
Abiraterone acetate
500 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 18, 2024
Approval ID
2ed6021f0d349561
Type
Therapeutic
Back to HSA Approvals
ABIRATERONE-TEVA FC TABLET 500 MG - HSA Drug Approval Details